SCHEMBL27769336

SCHEMBL27769336

CC(=O)Oc1cc(-c2ccccc2)cc(N)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ ITGB3 P05106 1/20 0.44
▸ ITGA2B P08514 1/20 0.44
▸ HMGB1 P09429 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ GGT1 P19440 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ NAPRT Q6XQN6 1/20 0.44
▸ BACE1 P56817 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ HTT P42858 1/20 0.42
▸ CFD P00746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28796445 0.82 BACE1 (0.42) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL27769325 0.81 TDP1 (0.44) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL3784778 0.81 CFD (0.56) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL3784538 0.81 HDAC2 (0.54) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL28794193 0.81 HDAC1 (0.41) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL27748175 0.78 HDAC1 (0.52) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL28781439 0.77 CRHBP (0.53) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL27776514 0.76 KDM4E (0.48) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL27827831 0.76 ACHE (0.54) TDP1KDM4EHSD17B10TSHRALDH1A1
SCHEMBL10492510 0.75 MAPT (0.50) TDP1KDM4EHSD17B10TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103214464-B Tetrazole-substituted arylamides and application of tetrazole-substituted arylamides using as p2x3 and p2x2/3 receptor antagonists HOFFMANN LA ROCHE 2015-02-18 — — CN disclosed
CN-102245586-B Thiadiazole-substituted arylamides HOFFMANN LA ROCHE 2014-07-09 — — CN disclosed
CN-101903355-B Imidazole-substituted arylamides HOFFMANN LA ROCHE 2014-05-14 — — CN disclosed
CN-101903348-B Pyrazole-substituted arylamides HOFFMANN LA ROCHE 2013-08-14 — — CN disclosed
CN-103159692-A Tetrazole-substituted arylamides HOFFMANN LA ROCHE 2013-06-19 — — CN disclosed
CN-101903359-B Triazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists HOFFMANN LA ROCHE 2013-05-22 — — CN disclosed
CN-101479250-B Tetrazole-substituted arylamides HOFFMANN LA ROCHE 2013-05-22 — — CN disclosed
CN-101528717-B Thiazole and oxazole-substituted arylamides HOFFMANN LA ROCHE 2013-04-24 — — CN disclosed
CN-102574778-A Novel biphenyl and phenyl-pyridine amides HOFFMANN LA ROCHE 2012-07-11 — — CN disclosed
CN-102438989-A Novel oxazolone and pyrrolidinone-substituted arylamides HOFFMANN LA ROCHE 2012-05-02 — — CN disclosed
CN-102245586-A Thiadiazole-substituted arylamides HOFFMANN LA ROCHE 2011-11-16 — — CN disclosed
CN-101903348-A Novel pyrazole-substituted arylamides HOFFMANN LA ROCHE 2010-12-01 — — CN disclosed
CN-101903355-A Novel imidazole-substituted arylamides HOFFMANN LA ROCHE 2010-12-01 — — CN disclosed
CN-101903359-A Triazole-substituted arylamide derivatives and their use as P2X3And/or P2X2/3Use of purinergic receptor antagonists HOFFMANN LA ROCHE 2010-12-01 — — CN disclosed
CN-101528717-A Thiazole and oxazole-substituted arylamides HOFFMANN LA ROCHE (CH) 2009-09-09 — — CN disclosed
CN-101479250-A Tetrazole-substituted arylamides HOFFMANN LA ROCHE (CH) 2009-07-08 — — CN disclosed
Send feedback